Dominique Limet - Articles and news items

ViiV Healthcare Logo

ViiV Healthcare announces new collaboration with Janssen to investigate single-tablet regimen for maintenance treatment of HIV-1

Industry news / 12 June 2014 / GlaxoSmithKline

Agreement is ViiV Healthcare’s first external collaboration for development of a two drug single-tablet combining dolutegravir and rilpivirine…

ViiV Healthcare Logo

ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1

Industry news, News / 12 August 2013 / GlaxoSmithKline

ViiV Healthcare is pleased to announce that the U.S. FDA has approved Tivicay® (dolutegravir) 50-mg tablets…

GlaxoSmithKline logo

Shionogi and ViiV Healthcare announce new agreement to commercialise and develop integrase inhibitor portfolio

Industry news, News / 29 October 2012 / GlaxoSmithKline

ViiV Healthcare Ltd and Shionogi & Co., Ltd., have entered into an agreement…

GlaxoSmithKline logo

Shionogi-ViiV Healthcare announces initial data from pivotal phase III study of dolutegravir in HIV

Industry news, News / 2 April 2012 / GlaxoSmithKline

SPRING-2 study meets primary endpoint of non-inferiority of dolutegravir…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...